Left ventricular dysfunction with reduced functional cardiac reserve in diabetic and non-diabetic LDL-receptor deficient apolipoprotein B100-only mice
about
Animal models of diabetic macrovascular complications: key players in the development of new therapeutic approachesHyperglycemia in apolipoprotein E-deficient mouse strains with different atherosclerosis susceptibility.Glibenclamide attenuates myocardial injury by lipopolysaccharides in streptozotocin-induced diabetic mice.Type 2 diabetes enhances arterial uptake of choline in atherosclerotic mice: an imaging study with positron emission tomography tracer ¹⁸F-fluoromethylcholineLDLR-/-ApoB100/100 mice with insulin-like growth factor II overexpression reveal a novel form of retinopathy with photoreceptor atrophy and altered morphology of the retinaThe innovative medicines initiative: a public private partnership model to foster drug discovery.Promoting blood vessel growth in ischemic diseases: challenges in translating preclinical potential into clinical success.Arterial Calcification in Diabetes Mellitus: Preclinical Models and Translational Implications.LRP5/canonical Wnt signalling and healing of ischemic myocardium.Ivabradine and metoprolol differentially affect cardiac glucose metabolism despite similar heart rate reduction in a mouse model of dyslipidemia.In vivo inhibition of nuclear factor of activated T-cells leads to atherosclerotic plaque regression in IGF-II/LDLR-/-ApoB100/100 mice.[18F]fluorodeoxyglucose uptake in atherosclerotic plaques is associated with reduced coronary flow reserve in mice.Increased Calcific Aortic Valve Disease in response to a diabetogenic, procalcific diet in the LDLr-/-ApoB100/100 mouse model.
P2860
Q26822630-8265E5BB-7337-4E31-8B59-A153C6149DC8Q30428421-A9AB9106-F448-4FB1-B1B5-1B33E5F34BF9Q34100205-0EC6F9A1-8B3A-4904-B936-ECD08C503EFAQ36553346-E5F1580B-5F55-46E6-AFDB-5FAF96191A8DQ37071378-BC6A87A0-DC3A-4ADF-BCB2-800B40613DFFQ37655104-ED0CA1B8-2D43-4938-B8E3-F44F2D388AF3Q38087578-B568FCA8-9DC2-49E6-B18C-89D942BDB2E1Q39071314-03F72DC5-714B-4FCF-BCCC-E3131EB40398Q48320252-04390F93-43E3-40E6-9011-CB48F907C48FQ51590601-208C27C3-0946-41F1-9570-40B42672D0AFQ52369139-A925557D-FF53-4AD3-B856-99FE22873A53Q52654525-2FA7FE6B-8520-4A45-B6D2-35B9EA521608Q52655804-0AF50A78-D90A-4A46-A834-32C0619167C5
P2860
Left ventricular dysfunction with reduced functional cardiac reserve in diabetic and non-diabetic LDL-receptor deficient apolipoprotein B100-only mice
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Left ventricular dysfunction w ...... apolipoprotein B100-only mice
@ast
Left ventricular dysfunction w ...... apolipoprotein B100-only mice
@en
type
label
Left ventricular dysfunction w ...... apolipoprotein B100-only mice
@ast
Left ventricular dysfunction w ...... apolipoprotein B100-only mice
@en
prefLabel
Left ventricular dysfunction w ...... apolipoprotein B100-only mice
@ast
Left ventricular dysfunction w ...... apolipoprotein B100-only mice
@en
P2093
P2860
P50
P356
P1476
Left ventricular dysfunction w ...... apolipoprotein B100-only mice
@en
P2093
Elina Loponen
Ivana Kholová
Mari Merentie
Marja Hedman
Petri I Mäkinen
Suvi E Heinonen
P2860
P2888
P356
10.1186/1475-2840-10-59
P407
P577
2011-06-30T00:00:00Z
P5875
P6179
1037125892